STAT

APRIL 21, 2025

High blood pressure earned its reputation as the silent killer by causing heart attacks, heart failure, and strokes. It’s also been a suspect in dementia. Some studies have hinted at a correlation between lower blood pressure and fewer dementia cases, but they were too small and too short to lend statistical significance to the link. It’s also been noted that people with untreated high blood pressure carry a 42% higher risk of developing dementia.

332

332

European Pharmaceutical Review

APRIL 21, 2025

For the first time in over ten years, the US Food and Drug Administration (FDA) has approved a new targeted treatment for chronic spontaneous urticaria. Sanofi and Regeneron Pharmaceuticals collaborated to develop Dupixent (dupilumab). Under the FDA’s new authorisation, the therapy is indicated for individuals aged 12 years and over with the chronic inflammatory skin disease, who still experience symptoms despite taking histamine-1 (H1) antihistamine medication.

105

105

STAT

APRIL 17, 2025

UnitedHealth Group on Thursday lowered its profit outlook for the rest of this year after the health care conglomerate said its Medicare Advantage members continued to seek more medical care than it anticipated.  The higher use of care among these Medicare enrollees “was most notable within physician and outpatient services,” UnitedHealth said in its first-quarter earnings release.

360

360

PharmaVoice

APRIL 16, 2025

Lower operating costs and a supply of high-skilled workers are helping the North Carolina region pull in billions of pharma manufacturing investments.

243

243

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Express Pharma

APRIL 16, 2025

The Ministry of Health and Family Welfare, Government of India, has issued a notification restricting the manufacture, sale and distribution of all formulations of the fixed dose combination (FDC) of Chlorpheniramine Maleate and Phenylephrine Hydrochloride for use in children below four years of age. The notification, dated 15 April 2025, was issued under Section 26A of the Drugs and Cosmetics Act, 1940 (23 of 1940), citing the potential risk of using the said FDC in children under four and the

Packaging 90

Packaging Labelling 90

STAT

APRIL 16, 2025

In a single day, 10,000 federal workers at the Centers for Disease Control and Prevention and the Food and Drug Administration were laid off, including 90% or more of those at the CDC’s National Institute for Occupational Safety and Health (NIOSH). The office may be little-known outside of public health circles, but it is of critical importance.

341

341

European Pharmaceutical Review

APRIL 22, 2025

New Phase III data has demonstrated the potential benefit of the monoclonal antibody obinutuzumab to treat lupus nephritis. This therapy is already approved for B cell malignancies. The REGENCY Phase III clinical trial evaluated 271 adults with active lupus nephritis, a severe complication of lupus that inhibits kidney function. Participants were randomised to receive either obinutuzumab plus mycophenolate mofetil and glucocorticoids as standard therapy, or a placebo plus standard therapy.

64

64

PharmaVoice

APRIL 18, 2025

Compass Pathways expects to publish the first phase 3 results from a large-scale, psilocybin drug trial by the end of this quarter.

221

221

Express Pharma

APRIL 16, 2025

Parexel, a global clinical research organisation (CRO) offering end-to-end Phase I to IV clinical development services, has announced the appointment of Charlotte Moser, MD, PhD, MBA, as its new Chief Medical Officer. The company stated that this leadership change aligns with its focus on advancing global clinical research through strategic drug development and therapeutic expertise.

Medical Schools 90

Medical Schools Drug Development 90

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

FDA Law Blog: Biosimilars

APRIL 21, 2025

By John W.M. Claud & Michelle L. Butler Recent reductions in force (RIFs) and leadership changes at FDA are already affecting key agency functionsand as the administration plans a broader reorganization, the impact will likely grow. One area drawing increasing attention is how these changes will affect the drug development and review process. As reported by the Wall Street Journal last week , reviews of both innovative and follow-on drugs have been caught in a traffic jam, largely due to a

Documentation 64

Documentation Drug Development 64

Pharmafile

APRIL 22, 2025

Galapagos NV has announced key leadership changes as it prepares to separate into two independent entities. Henry Gosebruch has been appointed founding CEO of the newly created subsidiary, currently named SpinCo. The subsidiary, which will operate independently following the split, is funded by Galapagos. Gosebruch joins SpinCo with extensive experience in business development and mergers […] The post Galapagos announces leadership changes amid planned company split appeared first on Pharm

64

64

PharmaVoice

APRIL 21, 2025

SpringWorks Therapeutics and the Children’s Tumor Foundation salvaged a shelved asset for neurofibromatosis and got it over the regulatory finish line.

173

173

Express Pharma

APRIL 16, 2025

Shilpa Medicare has announced that the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has approved its Investigational New Drug (IND) Nor Ursodeoxycholic Acid (Nor UDCA) Tablets 500 mg. The committee has also recommended granting marketing authorisation for the treatment of non-alcoholic fatty liver disease (NAFLD).

66

66

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Quality Matters

APRIL 17, 2025

Over half of the active pharmaceutical ingredients (API) for prescription medicines in the U.S. come from India and the European Union This blog is part of a series on the geographic concentration of pharmaceutical manufacturing. This blog focuses on the manufacturing of active pharmaceutical ingredients (API). For a discussion on finished dose manufacturing, seehere.

Pharmaceutical Manufacturing 64

Pharmaceutical Manufacturing 64

STAT

APRIL 22, 2025

Imagine a clinical trial with sedentary, overweight adults. One group is assigned to remain sedentary, the other to undergo intensive physical training with daily runs, calisthenics, and sports. After a week or two, the training group would probably feel sore and tired, and their endurance might be reduced. But we wouldn’t conclude that physical activity is bad for health.

315

315

Pharmafile

APRIL 16, 2025

Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed significantly longer progression-free survival (PFS) rates of newly diagnosed multiple myeloma (NDMM) than conventional bortezomib, lenalidomide and dexamethasone (VRd) chemotherapy. The treatment could help NDMM patients approach normal expectancy without their disease progressing, with PFS projected to be 17 years. […] The post Johnson & Johnson announces successful

Chemotherapy 66

Chemotherapy 66

Drug Patent Watch

APRIL 16, 2025

"Patent Expiration: The Secret to Unlocking $100 Billion in Pharmaceutical Value Did you know that patent expirations in the pharmaceutical industry are projected to unlock over $100 billion in new business opportunities? At Drug Patent Watch, we've analyzed the latest data to reveal the top 5 therapeutic areas poised for disruption. From oncology to cardiovascular disease, we've identified the key trends and insights you need to know to make informed investment decisions.

73

73

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Express Pharma

APRIL 22, 2025

As monoclonal antibody (mAb) therapies and biosimilars reshape the global biologics landscape with the mAbs market expected to grow from USD 233.19 billion in 2024 to reach around USD 919.06 billion by 2033 [1] Cytiva announced the launch of two advanced protein A chromatography resins: MabSelect SuRe 70 and MabSelect PrismA X. Developed to meet the evolving purification demands of biopharma innovators, these next-generation resins deliver enhanced productivity, durability, and affordability ac

Biosimilars 66

Biosimilars Drug Development 66

PharmaVoice

APRIL 22, 2025

The discoveries also hold potential benefits for patients with other conditions, such as chronic fatigue syndrome.

147

147

STAT

APRIL 17, 2025

WASHINGTON — The Food and Drug Administration will remove industry representatives from advisory committees and replace them with patients and caregivers, Commissioner Marty Makary announced Thursday.  While that’s not really a big change, it’s the latest effort by Makary and his boss, health secretary Robert F. Kennedy Jr., to reduce the influence of the pharmaceutical industry.

Drug Development 363

Drug Development 363

Pharma Marketing Network

APRIL 16, 2025

Imagine launching a brand campaign without guessworkwhere your message reaches the right healthcare professional at the right time on the right channel. Thats the promise of data-driven marketing , a strategy thats rapidly transforming how pharmaceutical companies approach promotion, education, and engagement in 2025. As privacy regulations evolve, customer expectations change, and AI-driven technologies emerge, pharma marketers must adapt or risk becoming irrelevant.

HIPAA 59

HIPAA Documentation Pharmaceutical Companies Pharmaceutical Companies 59

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

ID Stewardship

APRIL 16, 2025

In this article a current third year pharmacy student discusses pharmacy student study strategies to maximize learning in 2025 and beyond. Authored By:Fabian Quiroga, Pharm.D. Candidate 2026 Article posted 16 April 2025 No one really warns you about just how much content you will encounterin pharmacy school – until you are in it. Whether it is a single week, an entire module, or the full school year, the amount of material can feel overwhelming.

52

52

Express Pharma

APRIL 16, 2025

Glenmark Pharmaceuticals Inc., USA (Glenmark) has announced the upcoming launch of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulphate and Amphetamine Sulphate Tabletsalso referred to as Mixed Salts of a Single Entity Amphetamine Productin strengths of 5 mg, 10 mg, 15 mg, 20 mg and 30 mg. Glenmark confirmed that its product is bioequivalent and therapeutically equivalent to the reference listed drug, Adderall Tablets, marketed in the same strengths by Teva Womens Heal

66

66

PharmaVoice

APRIL 17, 2025

The non-traditional marketing approach comes amid a potential crackdown on TV drug ads.

147

147

STAT

APRIL 16, 2025

Welcome to Lab Dish , a new First Opinion column on regenerative medicine from Paul Knoepfler. I’m upbeat about cell therapy development for Parkinson’s disease, but it has been a marathon. Now two new clinical trial papers published Wednesday in Nature on stem cell-based therapies for Parkinson’s are another step forward. However, they also highlight remaining challenges and dilemmas, including the optimal doses of cells, the extent of engraftment, and whether to use alloge

333

333

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

BioPharma Dive

APRIL 21, 2025

A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug Wegovy two years after reporting initial Phase 3 results.

139

139

Pharmafile

APRIL 22, 2025

Meribel Pharma Solutions, a new mid-sized contract development and manufacturing organisation (CDMO), has officially launched with operations across 13 sites across France, Spain and Sweden. The company brings together facilities acquired from the Synerlab Group and seven former Recipharm manufacturing sites. The initiative seeks to enhance its services and solution capabilities.

59

59

Express Pharma

APRIL 16, 2025

Sun Pharmaceutical Industries has appointed Shaik Barak Tulla as its new Senior Vice President. The appointment strengthens Sun Pharmas senior leadership as it continues to expand operations across global markets. Shaik brings over 25 years of experience in the pharmaceutical sector. Before joining Sun Pharma, he served as Senior Vice President and Chief Commercial Head Acute Cluster at Cipla.

66

66